+ All Categories
Home > Documents > PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June...

PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June...

Date post: 20-Jan-2016
Category:
Upload: noah-willis
View: 215 times
Download: 0 times
Share this document with a friend
Popular Tags:
15
PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004
Transcript
Page 1: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

PDL eTechnology Update

ePocrates and Web PA

Overview for PDLIAG Implementation Advisory GroupJune 22, 2004

Page 2: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

CONFIDENTIAL: This document contains proprietary ideas, concepts, and other information which belong exclusively to ePocrates, Inc. Information disclosed herein should be considered proprietary and confidential. This document is the property of ePocrates Inc. and may not be disclosed, distributed, or reproduced without the express written consent of ePocrates, Inc.

1800 Gateway Drive, San Mateo, CA 94404

Phone: 650-227-1700 Fax: 650-227-2770

Scheduled for Implementation September 1, 2004

Page 3: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

350,000 active subscribers

8,300 in Virginia

140,000 (20%) physicians active subscribers

3,800 (23%) in Virginia

600 new users per day

A new physician joins every 14 minutes

68% of MDs with PDA have ePocrates

Over 20% of All U.S. Physicians Over 20% of All U.S. Physicians Currently Subscribe to ePocratesCurrently Subscribe to ePocratesOver 20% of All U.S. Physicians Over 20% of All U.S. Physicians Currently Subscribe to ePocratesCurrently Subscribe to ePocrates

Page 4: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

Blue Shield of California

Michigan Dept of Community Health

ePocrates PartnershipsMore than 90 Clients representing 85 million livesePocrates PartnershipsMore than 90 Clients representing 85 million lives

Page 5: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

Overview of ePocrates Rx® Features

Formulary menu

Drug nameFormulary status codes

Drug reference guide

Drug Information Formulary Information

MultiCheck™AutoUpdate

Page 6: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

Do Physicians Value ePocrates Do Physicians Value ePocrates Formulary Offering?Formulary Offering? 73%1 reported that the application improved workflow efficiency in

the practice because it decreased their reliance on formulary books and reduced the formulary-related pharmacy phone calls.

65%1 said that they provided a better quality of care since they were more likely to reference drug information before prescribing.

78%1 reported that the application is likely to influence their choice of prescription medications as it allows them to avoid pharmacy phone calls and offer patients a lower copay.

74%2 were unaware of formulary status changes in a timely manner, prior to using the application.

79%2 were “more likely to have a favorable impression of a health plan that lists its formulary information in ePocrates Rx Formulary than a health plan that does not.”

1 AdvancePCS–ePocrates Outpatient Study, September 2000. 2 ePocrates User Survey, June 2002 (939 respondents)

Page 7: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

Benefits to the Commonwealth of VirginiaBenefits to the Commonwealth of VirginiaBenefits to the Commonwealth of VirginiaBenefits to the Commonwealth of Virginia

Increase beneficiary satisfaction and quality of care

Manage rising administrative and drug costs

Improve provider relations through less administrative hassle

Page 8: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

Why should physicians use ePocrates Rx®?

50% of MDs estimated that using ePocrates Rx® has prevented on average at least 1 ADE on a weekly basis

65% rate high or very high the impact of the application on quality of care

73% of physicians rate high or very high the impact of the application on workflow efficiency in the practice2

Prior to using ePocrates Rx® with the formulary feature, 74% of physicians were unaware of formulary status changes in a timely manner3

Improve quality of care Improve workflow efficiency

Page 9: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

PDL Web Prior Authorization (PA)

Internet Based Technology

Page 10: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

PDL Web PA is a web based application.

It was developed in an effort to provide

authorized users with a web tool that will

enhance the process of submitting prior

authorizations.

Page 11: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

Ease of Use

Batch PA Requests

Check Status of Submitted PAs

Monitoring for Renewals

Review Drug Therapy Alternatives

Advantages of Web PA System

Page 12: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

Pediatrics

Family Practice Physicians

Long-Term Care Pharmacy

Internal Medicine Physicians

Academic Health Care Center

Beta Test Sites

Page 13: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

My PAs is a summary screen of PA requests made through the web

Page 14: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

View of a PA Request

Page 15: PDL eTechnology Update ePocrates and Web PA Overview for PDLIAG Implementation Advisory Group June 22, 2004.

View of Alternative Drug Therapy


Recommended